The majority of prior studies for the COVID-19 vaccinations -writ large- generate an efficacy range around 60 to 70 percent in prevention of COVID hospitalization. The efficacy for virus infection is essentially nil. The vaccine does nothing to prevent infection or transmission; their only claims are now a reduction in hospitalization rates.
Therapeutics, preventative medicines and healthy lifestyle choices to avoid negative outcomes, have been mostly ignored, often ridiculed, and largely downplayed by politicians, media and Big Pharma. Instead their preferred collective strategy has been a massive, overemphasized and almost exclusive effort to force vaccinations as the only medical option for SARS-CoV-2 infections.
The most studied and widespread therapeutic treatment on a global scale has been the use of an oral antiviral pill known as Ivermectin and a regime of supportive medications. Japan and India have embraced the Ivermectin protocol with reported large scale success rates.
However, the U.S., Europe and Australia have focused exclusively on treating and chasing the SARS-CoV-2 virus with vaccines for the virus and boosters for the variants.
Today Pfizer, the #1 vaccine maker on a global scale, is introducing their version of a pill form of therapeutic. With Ivermectin, a Merck product, costing somewhere around 30¢/dose, it appears Pfizer sees an opening for a $xx/dose pill option to enhance their growing profit margin. It is interesting to note the Pfizer study for their pill was conducted on a non-vaccinated population.
President Obama was well known for his diplomatic blunders, stumbles and curt demeanor with many foreign dignitaries including Queen Elizabeth II. Unsurprisingly it appears the JoeBama administration is picking up right where Obama left off.





